The United States government blocked a large investment (over $100 million) into one of Dr. David Sinclair's companies because the technology (age reversal) was deemed too dangerous for foreign companies and governments.

David Sinclair believes dying at 80 is not inevitable.

Dr. David Sinclair's lab is doing the first-ever trial of this type in humans to reverse aging, specifically treating blindness, as early as April 2026, pending FDA approval.

Dr. David Sinclair's lab introduces a set of three genes into the optic nerve at the back of the eye and turns them on for 6 to 8 weeks to reset the age of cells.

Dr. David Sinclair's lab has shown that they can now reverse the aging process.

Dr. David Sinclair has been studying aging, longevity, and age reversal for 30 years as a Harvard professor.